Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation.
Fischer
L
L
Department of Hepatobiliary Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Sterneck
M
M
Zöllner
B
B
Rogiers
X
X
D015075:2-Aminopurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D000077595:Famciclovir; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000502:physiology*; D011183:Postoperative Complications; D011355:Prodrugs / Q000627:therapeutic use; D011379:Prognosis; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors; D017211:Treatment Failure; D016896:Treatment Outcome
D000998:Antiviral Agents; D011355:Prodrugs; D019259:Lamivudine; D015075:2-Aminopurine; D000077595:Famciclovir